SML3106
7ACC2
≥98% (HPLC)
别名:
7-(N-Benzyl-N-methylamino)-2-oxo-2H-chromene-3-carboxylic acid, 7-ACC2, 7-Aminocarboxycoumarin 2, 7-[Benzyl(methyl)amino]-2-oxo-2H-chromene-3-carboxylic acid, 7-[Methyl(phenylmethyl)amino]-2-oxo-2H-1-benzopyran-3-carboxylic acid
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C18H15NO4
化学文摘社编号:
分子量:
309.32
UNSPSC Code:
12352200
NACRES:
NA.77
MDL number:
产品名称
7ACC2, ≥98% (HPLC)
InChI
1S/C18H15NO4/c1-19(11-12-5-3-2-4-6-12)14-8-7-13-9-15(17(20)21)18(22)23-16(13)10-14/h2-10H,11H2,1H3,(H,20,21)
InChI key
XTKDQPFUOFAMRL-UHFFFAOYSA-N
SMILES string
O=C(O)C1=CC2=C(C=C(C=C2)N(C)CC3=CC=CC=C3)OC1=O
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
2-8°C
Quality Level
Biochem/physiol Actions
7ACC2 is a monocarboxylate transporters MCT1 & MCT4 (SLC16A1 & SLC16A3) inhibitor that affects lactate uptake-dependent cancer growth in cultures (uptake/proliferation IC50 = 59/220 nM; MCT1/4-expressing SiHA cervix cancer in the absence of glucose) and in vivo (3 mg/kg/day i.p.; SiHa, HCT116, MCF-7 in mice), without affecting lactate efflux or the survival of highly glycolytic HL-60 (MCT1) or MDA-MB231 (MCT4) cancer cells. Unlike the MCT1/2 inhibitor AR-C155858, 7ACC2 does not block MCT1-mediated uptake of the anti-cancer drug 3-bromopyruvate (3-BP).
Monocarboxylate transporters MCT1 & MCT4 (SLC16A1 & SLC16A3) inhibitor that blocks lactate update-dependent cancer growth in vitro and in vivo.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持